Tykerb 250mg tablet – Blueberrypharma

Tykerb 250mg tablets are categorized as anti-neoplastic agent, which is orally active drug used for treating breast cancer.
Tykerb tablets are comes under biological category which is targeted chemotherapy.
Tykerb tablets are classified as;
1. Tyrosine kinase prohibitor
2. Stop the HER2/neu & epidermal growth factor receptor activity
3. Targeted therapy
4. Signal transduction prohibitor

PRODUCT DETAILS


Brand                    Tykerb
Ingredients            Lapatinib
Strength                250mg
Manufactured       GSK

DOSAGE


In HER2 positive advanced breast cancer:
The recommended dose of Tykerb is 1250mg should be administered orally as a single dose on day 1 to 21repeatedly combined with Capecitabine 2000mg/m2/day (should be taken orally in 2 doses relatively 12 hours apart) on day 1 to 14 in continuous 21 day cycle.
Totally 5 tablets of Tykerb should be taken at a time as whole.
In hormone receptor positive HER 2 positive advance breast cancer:
The prescribed dose is 1500mg should be administered orally as a single dose by combining with letrozole.
The prescribed dose of letrozole is 2.5mg as a once a day.
In these total 6 tablets of Tykerb should be administered as such.

SIDE EFFECTS


• Diarrhea
• Nausea
• Vomiting
• Stomatitis
• Back pain
• Dyspnea
• Insomnia
• Elevation of hemoglobulin, platelets, neutrophils
• Increase in AST & ALT, bilirubin
• Alopecia
• Pruritus
• Nail disorders
• Asthenia
• Headache
• Epistaxis
• Reduction of left ventricular ejection fraction
• Liver toxicity
• Interstitial lung disease
• Anaphylactic reactions
• Stevens Johnson syndrome
• Ventricular arrhythmias
• QT prolongation

CONTACT DETAILS

ADDRESS:

NEW NO. 3, Old No. 19, Cauvery Nagar 2nd Street, Kodungaiyur, chennai – 600 118.

PHONE:

+91-97890 77748

MAIL:

info@blueberrypharma.com

Comments

Post a Comment

Popular posts from this blog

Xtandi 40mg tablet - Uses & Side effects

Image
Xtandi 40mg Xtandi capsules belongs to nonsteroidal antiandrogen drug which is indicated for use in conjunction with castration to treat metastatic castration-resistant prostate cancer (mCRPC).  Xtandi 40mg capsule  is in the form of liquid – filled soft gelatin capsules administer via oral route. Each capsule consists of 40mg enzalutamide in the form of solution in caprylocaproyl polyoxylglycerides. PRODUCT DETAILS Brand Xtandi Ingredients Enzalutamide Strength 40mg Manufactured Astellas Xtandi 40mg tablet OVER DOSAGE In overdose condition treatment with Xtandi 40mg solid be stop and provide supportive measures care and monitor the vital signs. Multiple dose If administer ≤ 240mg no seizures is reported but when taking 360mg,480mg, and 600mg daily then 3 seizures were absorbed. If overdose occur, the patient will have high risk of seizures. ENZALUTAMIDE SIDE EFFECTS MORE COMMON Back pain; bloating of the face, arms, hands, lower leg
Read more

Crizalk 250mg Capsule- Crizotinib Uses & Side effects

CRIZALK 250MG DESCRIPTION Crizalk 250mg capsule is used for the therapy of patients with metastatic non-small cell lung cancer. Crizalk 250mg inhibits the anaplastic lymphoma kinase (ALK) and the c-MET/hepatocyte growth factor receptor. This action disturbs certain pathways in the cell, which can inhibit the growth of tumor cells. It is made specifically for the treatment of a type of lung cancer in which ALK is overactive due to an abnormality in the ALK gene. EXCRETION Crizalk is excreted via feces 63% and 22% via urine and half -life is 42 hours PRODUCT DETAILS Brand            Crizalk Ingredients     Crizotinib Strength            250mg Manufactured    Pfizer Ltd CRIZOTINIB SIDE EFFECTS • Infection increased • Breathlessness • Eyesight changes • Bowel changes • Feeling sick • Swelling of hands and feet’s • Decreased appetite • Fatigue • Liver changes • Skin rash • bradycardia STORAGE St
Read more

Hertab 250mg tablet – Blueberrypharma

Hertab 250mg tablets are categorized as anti-neoplastic agent, which is orally active drug used for treating breast cancer. Hertab tablets are comes under biological category which is targeted chemotherapy. Hertab tablets are classified as; 1. Tyrosine kinase prohibitor 2. Stop the HER2/neu & epidermal growth factor receptor activity 3. Targeted therapy 4. Signal transduction prohibitor PRODUCT DETAILS Brand               Hertab Ingredients        Lapatinib Strength           250mg Manufactured   Hetero DOSAGE In HER2 positive advanced breast cancer: The recommended dose of Hertab is 1250mg should be administered orally as a single dose on day 1 to 21repeatedly combined with Capecitabine 2000mg/m2/day (should be taken orally in 2 doses relatively 12 hours apart) on day 1 to 14 in continuous 21 day cycle. Totally 5 tablets of Hertab should be taken at a time as whole. In hormone receptor positive HER 2 positive advance breast cance
Read more